NetworkNewsBreaks – INmune Bio, Inc. (NASDAQ: IN
Post# of 33
(Total Views: 194)
Posted On: 09/24/2019 4:32:35 PM
NetworkNewsBreaks – INmune Bio, Inc. (NASDAQ: INMB) CEO Discusses Company Achievements in Interview; Director of Neuroscience to Present at World Immunotherapy Congress
RJ Tesi, M.D., co-founder and CEO of clinical-stage immunology company INmune Bio (NASDAQ: INMB), was recently featured in an interview with multimedia financial reporter Jason Lin. Among other highlights, Dr. Tesi discusses recent company accomplishments in the interview. “Nasdaq’s MarketSite is a premiere platform for INmune Bio to share our story with investors and to discuss recent developments in our programs for cancer, Alzheimer’s disease and nonalcoholic steatohepatitis (NASH) liver disease,” INmune co-founder and CEO Dr. RJ Tesi stated in the interview. “We hope to continue reaching new milestones in the development of therapies that target the innate immune system.” The company also announced today that CJ Barnum, Ph.D., Director of Neuroscience, will be presenting on “Approaching Alzheimer’s disease as an immunological disease: role of biomarkers” at the World Immunotherapy Congress taking place on October 16 in Switzerland.
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
RJ Tesi, M.D., co-founder and CEO of clinical-stage immunology company INmune Bio (NASDAQ: INMB), was recently featured in an interview with multimedia financial reporter Jason Lin. Among other highlights, Dr. Tesi discusses recent company accomplishments in the interview. “Nasdaq’s MarketSite is a premiere platform for INmune Bio to share our story with investors and to discuss recent developments in our programs for cancer, Alzheimer’s disease and nonalcoholic steatohepatitis (NASH) liver disease,” INmune co-founder and CEO Dr. RJ Tesi stated in the interview. “We hope to continue reaching new milestones in the development of therapies that target the innate immune system.” The company also announced today that CJ Barnum, Ph.D., Director of Neuroscience, will be presenting on “Approaching Alzheimer’s disease as an immunological disease: role of biomarkers” at the World Immunotherapy Congress taking place on October 16 in Switzerland.
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
(0)
(0)INmune Bio Inc. (INMB) Stock Research Links
Scroll down for more posts ▼